Latest Articles
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com
Published: Aug. 26, 2025, 4:10 p.m.
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer - Curetoday
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer Curetoday
Published: Aug. 26, 2025, 4:06 p.m.
Olaparib Maintenance in Advanced Endometrial Cancer Trial - BIOENGINEER.ORG
Olaparib Maintenance in Advanced Endometrial Cancer Trial BIOENGINEER.ORG
Published: Aug. 26, 2025, 3:07 p.m.
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer - OncLive
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer OncLive
Published: Aug. 26, 2025, 3:01 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) - Yahoo Finance
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) Yahoo Finance
Published: Aug. 26, 2025, noon
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature
Published: Aug. 26, 2025, 11:43 a.m.
Kirsten Storms Was ‘Taken Aback' When She Learned She'd Be Temporarily Replaced on ‘General Hospital' - MSN
Kirsten Storms Was ‘Taken Aback' When She Learned She'd Be Temporarily Replaced on ‘General Hospital' MSN
Published: Aug. 26, 2025, 4:46 a.m.
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India - geneonline.com
GSK Launches Jemperli for Advanced Endometrial Cancer and Zejula for Ovarian Cancer in India geneonline.com
Published: Aug. 25, 2025, 12:03 p.m.
GSK launches advanced cancer therapies Jemperli and Zejula in India - Business Upturn
GSK launches advanced cancer therapies Jemperli and Zejula in India Business Upturn
Published: Aug. 25, 2025, 5:42 a.m.
Has Cardlytics Inc. found a price floor - Trade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
Has Cardlytics Inc. found a price floor - Trade Risk Assessment & Advanced Swing Trade Entry Plans Newser
Published: Aug. 23, 2025, 5:41 a.m.
Link copied to clipboard!